Skip to main content
Chemistry and Biochemistry Labs
Van Ry Lab

Publications

1. Ellsworth, P. N., J. A. Herring, A. H. Leifer, J. D. Ray, W. S. Elison, P. D. Poulson, J. E. Crabtree, P. M. Van Ry and J. S. Tessem (2024). "CEBPA Overexpression Enhances β-Cell Proliferation and Survival." Biology (Basel) 13(2). https://doi.org/10.3390/biology13020110

2. Viglione, M. S., A. Saxton, D. Downs, A. T. Woolley, K. A. Christensen, P. M. Van Ry and G. P. Nordin (2024). "Integrated biocompatible 3D printed isoporous membranes with 7 μm pores." Lab Chip 24(8): 2202-2207. https://doi.org/10.1039/D4LC00014E

3. Chang, A., P. M. Van Ry, and G. Raghu (2023). "Idiopathic pulmonary fibrosis: aligning murine models to clinical trials in humans." Lancet Respir Med 11(11): 953-955. https://doi.org/10.1038/s41467-023-41272-z

4. Roy, A., L. Shi, A. Chang, X. Dong, A. Fernandez, J. C. Kraft, J. Li, V. Q. Le, R. V. Winegar, G. M. Cherf, D. Slocum, P. D. Poulson, G. E. Casper, M. L. Vallecillo-Zúniga, J. C. Valdoz, M. C. Miranda, H. Bai, Y. Kipnis, A. Olshefsky, T. Priya, L. Carter, R. Ravichandran, C. M. Chow, M. R. Johnson, S. Cheng, M. Smith, C. Overed-Sayer, D. K. Finch, D. Lowe, A. K. Bera, G. MatuteBello, T. P. Birkland, F. DiMaio, G. Raghu, J. R. Cochran, L. J. Stewart, M. G. Campbell, P. M. Van Ry, T. Springer and D. Baker (2023). "De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8." Nat Commun 14(1): 5660. https://doi.org/10.1038/s41467-023-41272-z

5. Yiran Liang, Thy Truong, Aubrianna J. Saxton, Hannah Boekweg, Samuel H. Payne, Pam M. Van Ry, and Ryan T. Kellyu. “HyperSCP: Compining Isotopic and Isobaric Labeling for Higher Throughput Single Cell Proteomics.” Analytical Chemistry 2023 95 (20), 8020-8027. https://doi.org/10.1021/acs.analchem.3c00906

6. Hirschi-Budge, K. M., K. Y. F. Tsai, K. L. Curtis, G. S. Davis, B. K. Theurer, A. M. M. Kruyer, K. W. Homer, A. Chang, P. M. Van Ry, J. A. Arroyo and P. R. Reynolds (2022). "RAGE signaling during tobacco smoke-induced lung inflammation and potential therapeutic utility of SAGEs." BMC Pulm Med 22(1): 160. https://doi.org/10.1186/s12890-022-01935-x

7. Vallecillo-Zúniga, M. L., M. Rathgeber, D. Poulson, B. Kartchner, J. Luddington, H. Gill, S. Hayes, M. Teynor, C. S. Stowell, C. M. Arthur, S. R. Stowell and P. M. Van Ry (2022). "Evaluating Therapeutic Activity of Galectin-1 in Sarcolemma Repair of Skeletal Muscle." Methods Mol Biol 2442: 663-683. https://link.springer.com/book/10.1007/978-1-0716-20557#about

8. Valdoz, J. C., N. A. Franks, C. G. Cribbs, D. J. Jacobs, E. L. Dodson, C. J. Knight, P. D. Poulson, S. Garfield, B. C. Johnson, B. M. Hemeyer, M. T. Sudo, J. A. Saunooke, M. L. Vallecillo-Zúniga, M. Santos, B. Chamberlain, K. A. Christensen, G. P. Nordin, Raghu, Ganesh and P. M. Van Ry, (2022) “Soluble ECM Promotes organotypic formation in lung alveolar model.” Biomaterials https://doi.org/10.1016/j.biomaterials.2022.121464

9. Valdoz, J. C., B. C. Johnson, D. J. Jacobs, N. A. Franks, E. L. Dodson, C. Sanders, C. G. Cribbs and P. M. Van Ry (2021). "The ECM: To Scaffold, or Not to Scaffold, That Is the Question." Int J Mol Sci 22(23). https://pubmed.ncbi.nlm.nih.gov/34884495/

10. Vallecillo-Zúniga, M. L., P. D. Poulson, J. S. Luddington, C. J. Arnold, M. Rathgeber, B. C. Kartchner, S. Hayes, H. Gill, J. C. Valdoz, J. L. Spallino, S. Garfield, E. L. Dodson, C. M. Arthur, S. R. Stowell and P. M. Van Ry (2021). "Therapeutic Benefit of Galectin-1: Beyond Membrane 5 Repair, a Multifaceted Approach to LGMD2B." Cells 10(11). https://doi.org/10.3390/life11060517.

11. Sanchez Noriega, J. L., N. A. Chartrand, J. C. Valdoz, C. G. Cribbs, D. A. Jacobs, D. Poulson, M. S. Viglione, A. T. Woolley, P. M. Van Ry, K. A. Christensen and G. P. Nordin (2021). "Spatially and optically tailored 3D printing for highly miniaturized and integrated microfluidics." Nat Commun 12(1): 5509. https://doi.org/10.1038/s41467-021-25788-w

12. Valdoz, J. C., D. J. Jacobs, C. G. Cribbs, B. C. Johnson, B. M. Hemeyer, E. L. Dodson, J. A. Saunooke, N. A. Franks, P. D. Poulson, S. R. Garfield, C. J. Knight and P. M. Van Ry (2021). "An Improved Scalable Hydrogel Dish for Spheroid Culture." Life (Basel) 11(6). https://doi.org/10.3390/cells10113210.

13. Vallecillo-Zúniga, M. L., M. F. Rathgeber, P. D. Poulson, S. Hayes, J. S. Luddington, H. N. Gill, M. Teynor, B. C. Kartchner, J. Valdoz, C. Stowell, A. R. Markham, C. Arthur, S. Stowell and P. M. Van Ry (2020). "Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models." PLoS One 15(9): e0238441. https://doi.org/10.1371/journal.pone.0238441

14. Warr, C., J. C. Valdoz, B. P. Bickham, C. J. Knight, N. A. Franks, N. Chartrand, P. M. Van Ry, K. A. Christensen, G. P. Nordin and A. D. Cook (2020). "Biocompatible PEGDA Resin for 3D Printing." ACS Appl Bio Mater 3(4): 2239-2244. https://doi.org/10.1021/acsabm.0c00055

15. Robinson, B. S., C. M. Arthur, B. Evavold, E. Roback, N. A. Kamili, C. S. Stowell, M. L. Vallecillo-Zúniga, P. M. Van Ry, M. Dias-Baruffi, R. D. Cummings and S. R. Stowell (2019). "The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function." Front Immunol 10: 1762. https://doi.org/10.3389/fimmu.2019.01762.

16. Wuebbles, R. D., V. Cruz, P. Van Ry, P. Barraza-Flores, P. D. Brewer, P. Jones and D. J. Burkin (2019). "Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy." Mol Ther Methods Clin Dev 13: 145153. https://pubmed.ncbi.nlm.nih.gov/30788383/

17. Willmann, R., H. Gordish-Dressman, S. Meinen, M. A. Rüegg, Q. Yu, K. Nagaraju, A. Kumar, M. Girgenrath, C. B. M. Coffey, V. Cruz, P. M. Van Ry, L. Bogdanik, C. Lutz, A. Rutkowski and D. J. Burkin (2017). "Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy." J Neuromuscul Dis 4(2): 115126. https://pubmed.ncbi.nlm.nih.gov/28550268/

18. Van Ry, P. M., T. M. Fontelonga, P. Barraza-Flores, A. Sarathy, A. M. Nunes and D. J. Burkin (2017). "ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies." Compr Physiol 7(4): 1519-1536. https://pubmed.ncbi.nlm.nih.gov/28915335/

19. Lewon, M., C. M. Peters, P. M. Van Ry, D. J. Burkin, K. W. Hunter and L. J. Hayes (2017). "Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures." Behav Processes 142: 8-20.

20. Doe, J., A. M. Kaindl, M. Jijiwa, M. de la Vega, H. Hu, G. S. Griffiths, T. M. Fontelonga, P. Barraza, V. Cruz, P. Van Ry, J. W. Ramos, D. J. Burkin and M. L. Matter (2017). "PTRH2 gene mutation causes progressive congenital skeletal muscle pathology." Hum Mol Genet 26(8): 1458-1464. https://pubmed.ncbi.nlm.nih.gov/28175314/

21. Griffiths, G. S., J. Doe, M. Jijiwa, P. Van Ry, V. Cruz, M. de la Vega, J. W. Ramos, D. J. Burkin and M. L. Matter (2015). "Bit-1 is an essential regulator of myogenic differentiation." J Cell Sci 128(9): 1707-1717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446732/

22. Van Ry, P. M., R. D. Wuebbles, M. Keys and D. J. Burkin (2015). "Galectin-1 protein therapy prevents pathology and improves muscle function in the mdx mouse model of Duchenne muscular dystrophy." Mol Ther. https://doi.org/10.1038/mt.2015.105

23. Van Ry, P. M., P. Minogue, B. L. Hodges and D. J. Burkin (2014). "Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy." Hum Mol Genet 23(2): 383-396. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869356/

Presentations

1. Saxton, Aubri J., Sia, Jhon and P. M. Van Ry (presenter), Development of Tissue Engineering Techniques for Investigations of Cell-ECM Crosstalk in NSCLC, June 9, 2024, Simmons Center for Cancer Research Series, BYU, Provo, UT

2. Pam M. Van Ry (presenter), Mary L. Vallecillo-Zúniga, Stefannia Esparza, Daniel Poulson, Ethan Durham, Luke Westhoff, Braden Kartchner, Colten Hansen, Carter Stowell, Parker Nelso1, Connie Arthur and Sean Stowell, Galectin-1 Treatment Improves Overall Muscle Health in LimbGirdle Muscular Dystrophy R2 Models, May 8-11, 2024, Jain Foundation Scientific Conference 2024, Huston, TX.

3. Saxton, Aubri J., Sia, Jhon and P. M. Van Ry (presenter), Development of Tissue Engineering Techniques for Investigations of Cell-ECM Crosstalk in NSCLC, May 2, 2024, Utah Cancer Research Symposium, University of Utah, SLC, UT 7

4. Vallecillo-Zúniga, M. L., P. D. Poulson, J. S. Luddington, C. J. Arnold, M. Rathgeber, B. C. Kartchner, S. Hayes, H. Gill, J. C. Valdoz, J. L. Spallino, S. Garfield, E. L. Dodson, C. M. Arthur, S. R. Stowell and P. M. Van Ry (presenter and session leader), Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B, April 20-23, 2023, The American Physiology Summit, Long Beach, CA.

5. Vallecillo-Zúniga, M. L., P. D. Poulson, J. S. Luddington, C. J. Arnold, M. Rathgeber, B. C. Kartchner, S. Hayes, H. Gill, J. C. Valdoz, J. L. Spallino, S. Garfield, E. L. Dodson, C. M. Arthur, S. R. Stowell and P. M. Van Ry (presenter), Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B, April 27-27, 2022, Jain Foundation: Dysferlin on Galectin-1 Therapy.

6. Valdoz, J. C., N. A. Franks, C. G. Cribbs, D. J. Jacobs, E. L. Dodson, C. J. Knight, P. D. Poulson, S. Garfield, B. C. Johnson, B. M. Hemeyer, M. T. Sudo, J. A. Saunooke, M. L. Vallecillo-Zúniga, M. Santos, B. Chamberlain, K. A. Christensen, G. P. Nordin, Raghu, Ganesh and P. M. Van Ry (presenter), Novel organotypic lung triculture technologies paving the way to personalized medicine, March 10, 2022, University of Utah and Intermountain Health Care pulmonary Division Grand Rounds.

7. Sanchez Noriega, J. L., N. A. Chartrand, J. C. Valdoz, M. S. Viglione, A. T. Woolley, P. M. Van Ry, K. A. Christensen and G. P. Nordin (presenter), Re-envisioned 3D Printing as an Enabler for Extreme Microfluidic Component Miniaturization, October 2021, Chemical and Biological Microsystems Socitey, MicroTAS, Palm Springs, California

8. Valdoz, J. C. (presenter), N. A. Franks, C. G. Cribbs, D. J. Jacobs, E. L. Dodson, C. J. Knight, P. D. Poulson, S. Garfield, B. C. Johnson, B. M. Hemeyer, M. T. Sudo, J. A. Saunooke, M. L. Vallecillo-Zúniga, M. Santos, B. Chamberlain, K. A. Christensen, G. P. Nordin, Raghu, Ganesh and P. M. Van Ry, Novel organotypic lung triculture technologies paving the way to personalized medicine, August 22-26, 2021, ACS, Division of Biochemical Technology, virtual.

9. Van Ry, PM (presenter), August 22-26, 2021, ACS, Division of Biochemical Technology (invited speaker), Novel organotypic lung triculture technologies paving the way to personalized medicine, hybrid meeting Atlanta, Georgia.

10. Van Ry, PM (presenter), June 14-15, 2021, 2nd Advanced Chemistry World Congress (invited speaker-virtual), Galectin-1 a novel protein therapy for LGMD2B, Berlin, Germany (hybrid meeting)

11. Van Ry, PM (presenter), March 15-18, 2021, MDA Clinical & Scientific Conference (invited speaker), Galectin-1 a novel protein therapy for LGMD2B, virtual meeting.

12. Van Ry, PM (presenter), February 20, 2020, Utah Center for Clinical and Translational Science Collaboration Meeting (invited speaker), Galectin-1 a novel protein therapy for LGMD2B.

13. Van Ry, PM, February 29th- March 1st, 2016, Protein Replacement Therapeutic Strategies: Part 2, (Invited speaker), LAMA2 CMD Scientific Meeting at Sick Kids, Galectin-1 treatment in LAMA2-CMD, Toronto, Canada.

14. Van Ry PM, Ryan D. Wuebbles, Jordan Tice, Vivian Cruz, Melissa Sacasas, Keely Thoreson, Tatiana M. Fontelonga and Dean J Burkin, June 28-July 2, 2016, Galectin-1 ameliorates disease pathology in two mouse models of Duchenne Muscular Dystrophy (Talk and poster), New Directions in Biology and disease of Skeletal Muscle Conference. Orlando, Florida at the Renaissance Orlando at SeaWorld

15. Van Ry, PM, Priscilla Minogue, Bradley L. Hodges and Dean J. Burkin, January 2013. Laminin111 protein therapy improves muscle repair in mouse model for merosin-deficient congenital muscular dystrophy. Abstract for oral presentation, 30th Annual George G. Bierkamper Student Research Convocation, University of Nevada-Reno School of Medicine, Reno, NV.

16. Van Ry PM, January 11, 2012. The Role of Large on α7β1 integrin. Abstract for oral presentation, 29th Annual George G. Bierkamper Student Research Convocation, University of Nevada-Reno School of Medicine, Reno, NV. 6

17. Van Ry PM, August 2011. The Role of LARGE on α7β1 integrin. Abstract for oral presentation, Annual Bioscience Retreat, University of Nevada-Reno, Reno, NV.

18. Van Ry, PM, Priscilla Minogue, Ryan D. Wuebbles, Dean J. Burkin, August 2013. Galectin-1 protein therapy for the treatment of Duchenne Muscular Dystrophy. Abstract for oral presentation, Annual Bioscience Retreat, University of Nevada-Reno School of Medicine, Reno, NV.